Clinical Trial Update: Clinical Trial to eLiminate HCV-infection in Treatment-naïve, Renally Impaired EgyptiAn Patients on Renal Dialysis, With Chronic Hepatitis C Genotype 4 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial targeting elimination of HCV infection in treatment-naïve, renally impaired Egyptian patients on dialysis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Hepatitis C Virus Infection, Response to Therapy of | Phase 4 | Status: WITHDRAWN